In a 2023 study from Turkey, the rate of active TB among patients receiving anti-TNF therapy was 0.97%, similar to our result; however, that study used 2017 TB incidence data (14.6 per 100,000), yielding a 66-fold increased risk [23]. Here, TNF is linked to tuberculosis.